You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glioblastoma

Showing 1 - 25 of 2,170
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, Glioma Trial (drug, procedure, diagnostic test)

Not yet recruiting
  • Glioblastoma
  • Glioma
  • (no location specified)
Nov 7, 2022

Recurrent Glioblastoma Trial (fractionated radiotherapy, cadonilimab)

Not yet recruiting
  • Recurrent Glioblastoma
  • (no location specified)
Feb 20, 2023

MGMT-Unmethylated Glioblastoma Trial (Etoposide Plus Cisplatin)

Not yet recruiting
  • MGMT-Unmethylated Glioblastoma
  • Etoposide Plus Cisplatin
  • (no location specified)
Jan 12, 2023

Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,

Active, not recruiting
  • Giant Cell Glioblastoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Jan 4, 2023

Experiences of Glioblastoma Patients

Not yet recruiting
  • Glioblastoma
    • (no location specified)
    Feb 4, 2023

    Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine

    Recruiting
    • Glioblastoma, IDH-wildtype
    • +4 more
    • Eflornithine (Dose Level 1)
    • +3 more
    • Cleveland, Ohio
      The Cleveland Clinic
    May 19, 2023

    Glioblastoma Through Preservation of Biologically Active Brain

    Not yet recruiting
    • Glioblastoma
    • +2 more
    • Specimen Collection
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    Feb 24, 2023

    Glioblastoma Multiforme Trial in Shijia Zhuang (TMZ)

    Recruiting
    • Glioblastoma Multiforme
    • Shijia Zhuang, Hebei, China
      the Second Hospital of HeBei Medical University
    Oct 18, 2022

    Glioblastoma Trial in Aarhus (Escalated proton therapy)

    Not yet recruiting
    • Glioblastoma
    • Escalated proton therapy
    • Aarhus, Denmark
      Danish Center for Particle Therapy
    Mar 2, 2023

    Glioblastoma Multiforme Trial (WP1066)

    Not yet recruiting
    • Glioblastoma Multiforme
    • (no location specified)
    May 18, 2023

    Glioblastoma Multiforme, Glioblastoma, Adult, Glioma of Brain Trial in Geneva (IMA950/Poly-ICLC, IMA950/Poly-ICLC and

    Active, not recruiting
    • Glioblastoma Multiforme
    • +3 more
    • Geneva, Switzerland
      University Hospitals of Geneva
    Dec 23, 2022

    Glioblastoma Trial in Louisville (Pembrolizumab and Temozolomide)

    Recruiting
    • Glioblastoma
    • Pembrolizumab and Temozolomide
    • Louisville, Kentucky
      James Graham Brown Cancer Ctr.
    Jan 18, 2023

    Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))

    Active, not recruiting
    • Glioblastoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Jan 30, 2023

    Glioblastoma, Glioblastoma, IDH-wildtype Trial in Rome (Biomolecular tumor analysis)

    Recruiting
    • Glioblastoma
    • Glioblastoma, IDH-wildtype
    • Biomolecular tumor analysis
    • Rome, Italy
      Fondazione Policlinico Universitario A. Gemelli IRCCS
    Mar 6, 2023

    Glioblastoma Trial in Strasbourg (Simultaneous-integrated boost with IMRT)

    Not yet recruiting
    • Glioblastoma
    • Simultaneous-integrated boost with IMRT
    • Strasbourg, France
      Institut de cancérologie Strasbourg Europe
    Dec 7, 2022

    Glioblastoma Trial (MRI scan using USPIO particles)

    Not yet recruiting
    • Glioblastoma
    • MRI scan using USPIO particles
    • (no location specified)
    Dec 15, 2022

    Glioblastoma Trial (Gabapentin, Sulfasalazine, Memantine)

    Not yet recruiting
    • Glioblastoma
    • (no location specified)
    Dec 15, 2022

    Recurrent Glioblastoma Trial (Niraparib, Re-irradiation (re-RT))

    Not yet recruiting
    • Recurrent Glioblastoma
    • (no location specified)
    Dec 23, 2022

    Response and Progression in Glioblastoma

    Terminated
    • Glioblastoma
    • Glioblastoma Multiforme
    • MRI
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Jan 12, 2023

    Recurrent Glioblastoma Trial (Sintilimab plus Bevacizumab and Temozolomide)

    Not yet recruiting
    • Recurrent Glioblastoma
    • Sintilimab plus Bevacizumab and Temozolomide
    • (no location specified)
    Nov 27, 2022

    Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)

    Active, not recruiting
    • Astrocytoma, Grade IV
    • +3 more
    • Radiation
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

    Recruiting
    • Astrocytoma, Grades II, III and IV
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 31, 2023

    Glioblastoma Trial in Lund (Salovum, Placebo egg yolk powder)

    Recruiting
    • Glioblastoma
    • Salovum
    • Placebo egg yolk powder
    • Lund, Sweden
      Skåne University Hospital
    Dec 30, 2022

    Glioblastoma Trial (Tislelizumab and Bevacizumab)

    Not yet recruiting
    • Glioblastoma
    • Tislelizumab and Bevacizumab
    • (no location specified)
    Apr 12, 2023

    Glioblastoma, Glioblastoma Multiforme Trial in Saint Louis (device, procedure, genetic)

    Recruiting
    • Glioblastoma
    • Glioblastoma Multiforme
    • Sonobiopsy
    • +3 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Sep 21, 2022